sorafenib has been researched along with diorcinol in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (diorcinol) | Trials (diorcinol) | Recent Studies (post-2010) (diorcinol) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 5 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, T; Chang, FR; Chuang, DW; Chung, YM; El-Shazly, M; Hsieh, CT; Hsieh, TJ; Hwang, TL; Oshima, Y; Wei, CK; Wu, YC | 1 |
1 other study(ies) available for sorafenib and diorcinol
| Article | Year |
|---|---|
An epigenetic modifier enhances the production of anti-diabetic and anti-inflammatory sesquiterpenoids from Aspergillus sydowii.
Topics: 3T3-L1 Cells; Animals; Anti-Inflammatory Agents; Aspergillus; Azacitidine; DNA Modification Methylases; Glucose; Humans; Hypoglycemic Agents; Industrial Microbiology; Mice; Neutrophils; Sesquiterpenes; Superoxides | 2013 |